E-7564: Petition to the Minister of Health — Canadian Petition Tracker
Canonical URL: https://petitiontracker.ca/petition/e-7564
Track petition E-7564 — "Petition to the Minister of Health" sponsored by Helena Jaczek. 22 signatures and counting. See signature growth trends and provincial breakdown on PetitionTracker.ca.
Petition Text
Petition to the Minister of Health
Whereas:
• The public funding negotiations for Elahere (mirvetuximab soravtansine) have experienced extensive delays, after initial negotiations concluding with no agreement;
• In treating ovarian cancer, Elahere has been proven to be more effective than traditional funded chemotherapies (see study in the New England Journal of Medicine);
• Elahere has side effects that are different from traditionally used chemotherapies, which make it a better choice for many patients with underlying conditions, like Crohn's Disease; and
• Exorbitant medication costs unfairly disadvantage vulnerable communities, cutting them off from life-changing care. Citizens deserve a healthcare system that funds the most effective treatments available.
We, the undersigned, citizens of Canada, call upon the Minister of Health to instruct the pCPA (Pan-Canadian Pharmaceutical Alliance) to restart negotiations with the manufacturer of Elahere (AbbVie), with a mandate of reaching an agreement that will see Elahere become a funded treatment option for patients suffering from ovarian, fallopian tube and peritoneal cancers, across the country.